Carnegie, Australia

Barry Thomas Hunt

USPTO Granted Patents = 2 



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Barry Thomas Hunt: Innovator in Pharmaceutical Delivery Systems

Introduction

Barry Thomas Hunt is a notable inventor based in Carnegie, Australia. He has made significant contributions to the field of pharmaceutical delivery systems, particularly through his innovative approaches to topical compositions. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.

Latest Patents

Hunt's latest patents focus on pharmaceutical foam technology. The inventions provide various pharmaceutically active topical delivery compositions contained in a pressurized container. These compositions utilize a quick-breaking alcoholic foaming agent, which forms a temperature-sensitive foam upon release. The patents also detail methods for modulating foam characteristics, improving the shelf-life of active compounds, and treating various diseases and infections through percutaneous methods.

Career Highlights

Throughout his career, Barry Thomas Hunt has worked with reputable companies such as Connetics Australia Pty Ltd and Stiefel Research Australia Pty Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of effective treatment solutions.

Collaborations

Hunt has collaborated with notable professionals in the field, including Albert Zorko Abram and Lilian Fuchshuber. These partnerships have further enhanced his research and development efforts in pharmaceutical technologies.

Conclusion

Barry Thomas Hunt's contributions to pharmaceutical delivery systems exemplify the importance of innovation in healthcare. His patents and career achievements reflect a commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…